Fifth Third Bancorp
HZNP

Fifth Third Bancorp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fifth Third Bancorp’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,476
Closed -$171K – 2701
2023
Q3 		$171K Buy
1,476
+338
+30% +$36.3K ﹤0.01% 989
2023
Q2 		$117K Buy
1,138
+389
+52% +$41K ﹤0.01% 1102
2023
Q1 		$81.7K Sell
749
-475
-39% -$52.5K ﹤0.01% 1272
2022
Q4 		$139K Sell
1,224
-145
-11% -$12K ﹤0.01% 1032
2022
Q3 		$85K Sell
1,369
-78,883
-98% -$5.51M ﹤0.01% 1151
2022
Q2 		$6.4M Sell
80,252
-2,997
-4% -$284K 0.03% 289
2022
Q1 		$8.76M Sell
83,249
-68
-0.1% -$6.63K 0.04% 279
2021
Q4 		$8.98M Sell
83,317
-784
-0.9% -$85.5K 0.03% 283
2021
Q3 		$9.21M Sell
84,101
-4,946
-6% -$513K 0.04% 263
2021
Q2 		$8.34M Buy
89,047
+1,819
+2% +$167K 0.04% 278
2021
Q1 		$8.03M Buy
87,228
+86,111
+7,709% +$7.27M 0.04% 280
2020
Q4 		$82K Sell
1,117
-2,604
-70% -$194K ﹤0.01% 1214
2020
Q3 		$289K Sell
3,721
-5,892
-61% -$405K ﹤0.01% 761
2020
Q2 		$534K Sell
9,613
-3,999
-29% -$171K ﹤0.01% 619
2020
Q1 		$403K Sell
13,612
-2,097
-13% -$70.9K ﹤0.01% 645
2019
Q4 		$569K Buy
15,709
+18
+0.1% +$552 ﹤0.01% 625
2019
Q3 		$427K Sell
15,691
-2,391
-13% -$61.8K ﹤0.01% 674
2019
Q2 		$435K Buy
18,082
+2,164
+14% +$54.9K ﹤0.01% 662
2019
Q1 		$421K Sell
15,918
-8,018
-33% -$190K ﹤0.01% 657
2018
Q4 		$468K Sell
23,936
-6,371
-21% -$125K ﹤0.01% 623
2018
Q3 		$593K Buy
30,307
+29,151
+2,522% +$554K ﹤0.01% 640
2018
Q2 		$19K Buy
+1,156
New +$17.6K ﹤0.01% 1687
2017
Q2 		– Sell
-4,430
Closed -$65K – 2307
2017
Q1 		$65K Buy
4,430
+962
+28% +$15.6K ﹤0.01% 1213
2016
Q4 		$56K Buy
+3,468
New +$62.9K ﹤0.01% 1303
2016
Q1 		– Sell
-68
Closed -$1K – 2812
2015
Q4 		$1K Sell
68
-83
-55% -$1.62K ﹤0.01% 2683
2015
Q3 		$3K Sell
151
-44,296
-100% -$1.4M ﹤0.01% 2548
2015
Q2 		$1.54M Buy
44,447
+24,233
+120% +$740K 0.01% 497
2015
Q1 		$525K Buy
+20,214
New +$371K ﹤0.01% 747

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fifth Third Bancorp's HZNP Position: Q4 2023 in Review

Fifth Third Bancorp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,476 shares — an estimated $171K sold.

Fifth Third Bancorp first reported a position in HZNP in Q1 2015 and held it in 28 quarters. The position peaked at $9.21M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Fifth Third Bancorp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,476 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $171K.
  • Fifth Third Bancorp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 28 quarters.
  • Fifth Third Bancorp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $9.21M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Fifth Third Bancorp's 13F filing for Q4 2023, filed 19 Jan 2024.